chlorhexidine has been researched along with Fungemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farinetto, C; Guenezan, J; Lepape, A; Lucet, JC; Maunoury, F; Mimoz, O; Pascal, J; Ruckly, S; Souweine, B; Timsit, JF | 1 |
| Borecki, IB; Boyle, WA; Buchman, TG; Coopersmith, CM; Fraser, VJ; Mazuski, JE; Nemeth, JL; Schallom, ME; Schuerer, DJ; Sona, CS; Thomas, J; Venker, M; Verjan, L; Ward, MR; Warren, DK; Zack, JE | 1 |
| Cauda, R; Tacconelli, E; Tumbarello, M | 1 |
2 trial(s) available for chlorhexidine and Fungemia
| Article | Year |
|---|---|
Cost-effectiveness analysis of chlorhexidine-alcohol versus povidone iodine-alcohol solution in the prevention of intravascular-catheter-related bloodstream infections in France.
Topics: 2-Propanol; Alcohols; Bacteremia; Catheter-Related Infections; Chlorhexidine; Cost-Benefit Analysis; Ethanol; Female; France; Fungemia; Humans; Intensive Care Units; Length of Stay; Male; Models, Economic; Povidone-Iodine; Treatment Outcome | 2018 |
Effect of chlorhexidine/silver sulfadiazine-impregnated central venous catheters in an intensive care unit with a low blood stream infection rate after implementation of an educational program: a before-after trial.
Topics: Adult; Aged; Anti-Infective Agents, Local; Bacteremia; Catheterization, Central Venous; Catheters, Indwelling; Chlorhexidine; Cross Infection; Female; Fungemia; Humans; Intensive Care Units; Male; Middle Aged; Silver Sulfadiazine | 2007 |
1 other study(ies) available for chlorhexidine and Fungemia
| Article | Year |
|---|---|
Central venous catheters and bloodstream infection.
Topics: Anti-Infective Agents, Local; Catheterization, Central Venous; Chlorhexidine; Disinfectants; Fungemia; Humans; Immunocompromised Host; Sepsis; Silver Sulfadiazine | 2000 |